Possia Union européenne - anglais - EMA (European Medicines Agency)

possia

astrazeneca ab - ticagrelor - peripheral vascular diseases; acute coronary syndrome - antithrombotic agents - possia, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with acute coronary syndromes (unstable angina, non-st-elevation myocardial infarction [nstemi] or st-elevation myocardial infarction [stemi]); including patients managed medically, and those who are managed with percutaneous coronary intervention (pci) or coronary artery by-pass grafting (cabg).

NEXIUM MUPS TABLET 20 mg Singapour - anglais - HSA (Health Sciences Authority)

nexium mups tablet 20 mg

astrazeneca singapore pte ltd - esomeprazole magnesium trihydrate 22.3mg eqv esomeprazole - tablet, film coated - 20 mg - esomeprazole magnesium trihydrate 22.3mg eqv esomeprazole 20 mg

NEXIUM MUPS TABLET 40 mg Singapour - anglais - HSA (Health Sciences Authority)

nexium mups tablet 40 mg

astrazeneca singapore pte ltd - esomeprazole magnesium trihydrate 44.5mg eqv esomeprazole - tablet, film coated - 40 mg - esomeprazole magnesium trihydrate 44.5mg eqv esomeprazole 40 mg

PULMICORT TURBUHALER 100 mcgdose Singapour - anglais - HSA (Health Sciences Authority)

pulmicort turbuhaler 100 mcgdose

astrazeneca singapore pte ltd - budesonide - powder, metered - 100 mcg/dose - budesonide 100 mcg/dose